CN107156801A - 一种具有生发的活性菌丝群组合物及其制备方法 - Google Patents
一种具有生发的活性菌丝群组合物及其制备方法 Download PDFInfo
- Publication number
- CN107156801A CN107156801A CN201610127597.5A CN201610127597A CN107156801A CN 107156801 A CN107156801 A CN 107156801A CN 201610127597 A CN201610127597 A CN 201610127597A CN 107156801 A CN107156801 A CN 107156801A
- Authority
- CN
- China
- Prior art keywords
- mycelium
- mushroom
- wild
- preparation
- group compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000004209 hair Anatomy 0.000 title claims abstract description 45
- 238000002360 preparation method Methods 0.000 title claims abstract description 44
- 230000001256 tonic effect Effects 0.000 title claims abstract description 43
- 150000001875 compounds Chemical class 0.000 title claims abstract description 36
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims abstract description 57
- 244000269722 Thea sinensis Species 0.000 claims abstract description 25
- 235000009569 green tea Nutrition 0.000 claims abstract description 25
- 244000103635 Lyophyllum ulmarium Species 0.000 claims abstract description 24
- 235000015934 Lyophyllum ulmarium Nutrition 0.000 claims abstract description 24
- 241000222336 Ganoderma Species 0.000 claims abstract description 23
- 241000121220 Tricholoma matsutake Species 0.000 claims abstract description 23
- 241001494479 Pecora Species 0.000 claims abstract description 22
- 240000000599 Lentinula edodes Species 0.000 claims abstract description 21
- 241001063964 Boletus aereus Species 0.000 claims abstract description 19
- 241001506047 Tremella Species 0.000 claims abstract description 19
- 235000009024 Ceanothus sanguineus Nutrition 0.000 claims abstract description 16
- 240000003553 Leptospermum scoparium Species 0.000 claims abstract description 16
- 235000015459 Lycium barbarum Nutrition 0.000 claims abstract description 16
- 238000000926 separation method Methods 0.000 claims description 27
- 238000000605 extraction Methods 0.000 claims description 24
- 239000000203 mixture Substances 0.000 claims description 14
- 241000233866 Fungi Species 0.000 claims description 13
- 239000000284 extract Substances 0.000 claims description 10
- 210000004185 liver Anatomy 0.000 claims description 10
- 239000000843 powder Substances 0.000 claims description 9
- 239000002775 capsule Substances 0.000 claims description 8
- 241000283690 Bos taurus Species 0.000 claims description 7
- 239000012141 concentrate Substances 0.000 claims description 7
- 241000222532 Agrocybe Species 0.000 claims description 6
- 241000894006 Bacteria Species 0.000 claims description 6
- 238000000855 fermentation Methods 0.000 claims description 6
- 230000004151 fermentation Effects 0.000 claims description 6
- 238000009472 formulation Methods 0.000 claims description 5
- 238000001291 vacuum drying Methods 0.000 claims description 5
- 244000003416 Asparagus officinalis Species 0.000 claims description 4
- 235000005340 Asparagus officinalis Nutrition 0.000 claims description 4
- 244000251953 Agaricus brunnescens Species 0.000 claims description 3
- 240000001426 Amorpha canescens Species 0.000 claims description 3
- 235000015911 Amorpha canescens Nutrition 0.000 claims description 3
- 241000190633 Cordyceps Species 0.000 claims description 3
- 235000013629 Lippia javanica Nutrition 0.000 claims description 3
- 241000283903 Ovis aries Species 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 3
- 230000008569 process Effects 0.000 claims description 3
- 230000008014 freezing Effects 0.000 claims 2
- 238000007710 freezing Methods 0.000 claims 2
- 244000285940 beete Species 0.000 claims 1
- 235000011222 chang cao shi Nutrition 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 18
- 235000015961 tonic Nutrition 0.000 description 31
- 210000001519 tissue Anatomy 0.000 description 24
- 239000008280 blood Substances 0.000 description 14
- 229940024606 amino acid Drugs 0.000 description 13
- 235000001014 amino acid Nutrition 0.000 description 13
- 150000001413 amino acids Chemical class 0.000 description 13
- 210000004369 blood Anatomy 0.000 description 13
- 210000002784 stomach Anatomy 0.000 description 11
- 206010028980 Neoplasm Diseases 0.000 description 10
- 235000018102 proteins Nutrition 0.000 description 9
- 102000004169 proteins and genes Human genes 0.000 description 9
- 210000000952 spleen Anatomy 0.000 description 9
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 8
- 210000003780 hair follicle Anatomy 0.000 description 8
- 108090000623 proteins and genes Proteins 0.000 description 8
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 7
- 230000001093 anti-cancer Effects 0.000 description 7
- 239000011575 calcium Substances 0.000 description 7
- 229910052791 calcium Inorganic materials 0.000 description 7
- 201000011510 cancer Diseases 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 150000004676 glycans Chemical class 0.000 description 7
- 229910052500 inorganic mineral Inorganic materials 0.000 description 7
- 239000011707 mineral Substances 0.000 description 7
- 235000010755 mineral Nutrition 0.000 description 7
- 229920001282 polysaccharide Polymers 0.000 description 7
- 239000005017 polysaccharide Substances 0.000 description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- 210000003734 kidney Anatomy 0.000 description 6
- 230000001603 reducing effect Effects 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 230000036039 immunity Effects 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 206010022437 insomnia Diseases 0.000 description 5
- 150000002632 lipids Chemical class 0.000 description 5
- 230000007774 longterm Effects 0.000 description 5
- 206010011224 Cough Diseases 0.000 description 4
- 241001248610 Ophiocordyceps sinensis Species 0.000 description 4
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 4
- 230000003712 anti-aging effect Effects 0.000 description 4
- 210000001367 artery Anatomy 0.000 description 4
- 208000006673 asthma Diseases 0.000 description 4
- 150000001720 carbohydrates Chemical class 0.000 description 4
- 235000014633 carbohydrates Nutrition 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 229910052742 iron Inorganic materials 0.000 description 4
- 238000005728 strengthening Methods 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 239000011701 zinc Substances 0.000 description 4
- 229910052725 zinc Inorganic materials 0.000 description 4
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 3
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 3
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 3
- 208000001953 Hypotension Diseases 0.000 description 3
- 229930195725 Mannitol Natural products 0.000 description 3
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 3
- 229930003471 Vitamin B2 Natural products 0.000 description 3
- 229930003268 Vitamin C Natural products 0.000 description 3
- 206010047700 Vomiting Diseases 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 238000001467 acupuncture Methods 0.000 description 3
- 208000007502 anemia Diseases 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 230000000840 anti-viral effect Effects 0.000 description 3
- 230000003796 beauty Effects 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 235000013339 cereals Nutrition 0.000 description 3
- 210000004720 cerebrum Anatomy 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000002218 hypoglycaemic effect Effects 0.000 description 3
- 208000021822 hypotensive Diseases 0.000 description 3
- 230000001077 hypotensive effect Effects 0.000 description 3
- 230000036737 immune function Effects 0.000 description 3
- 206010022000 influenza Diseases 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 239000000594 mannitol Substances 0.000 description 3
- 235000010355 mannitol Nutrition 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 239000011574 phosphorus Substances 0.000 description 3
- 229910052698 phosphorus Inorganic materials 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 235000019164 vitamin B2 Nutrition 0.000 description 3
- 239000011716 vitamin B2 Substances 0.000 description 3
- 235000019154 vitamin C Nutrition 0.000 description 3
- 239000011718 vitamin C Substances 0.000 description 3
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- 229930024421 Adenine Natural products 0.000 description 2
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 2
- 206010003694 Atrophy Diseases 0.000 description 2
- 102000040350 B family Human genes 0.000 description 2
- 108091072128 B family Proteins 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 2
- LIEMBEWXEZJEEZ-UHFFFAOYSA-N D-threo-Leutysin Natural products NC1=NC=NC2=C1N=CN2CC(O)C(O)C(O)=O LIEMBEWXEZJEEZ-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- 244000000626 Daucus carota Species 0.000 description 2
- 235000002767 Daucus carota Nutrition 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 2
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 208000003351 Melanosis Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 2
- 235000011613 Pinus brutia Nutrition 0.000 description 2
- 241000018646 Pinus brutia Species 0.000 description 2
- 208000034189 Sclerosis Diseases 0.000 description 2
- 201000005010 Streptococcus pneumonia Diseases 0.000 description 2
- 241000193998 Streptococcus pneumoniae Species 0.000 description 2
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 2
- 239000004473 Threonine Substances 0.000 description 2
- 229930003451 Vitamin B1 Natural products 0.000 description 2
- 229930003316 Vitamin D Natural products 0.000 description 2
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 229960000643 adenine Drugs 0.000 description 2
- 229930013930 alkaloid Natural products 0.000 description 2
- 150000003797 alkaloid derivatives Chemical class 0.000 description 2
- 230000002082 anti-convulsion Effects 0.000 description 2
- 230000000118 anti-neoplastic effect Effects 0.000 description 2
- 230000000767 anti-ulcer Effects 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 230000006793 arrhythmia Effects 0.000 description 2
- 206010003119 arrhythmia Diseases 0.000 description 2
- 230000037444 atrophy Effects 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 238000002512 chemotherapy Methods 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 230000004064 dysfunction Effects 0.000 description 2
- -1 ergot Substances 0.000 description 2
- 235000020776 essential amino acid Nutrition 0.000 description 2
- 239000003797 essential amino acid Substances 0.000 description 2
- 230000029142 excretion Effects 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 239000003163 gonadal steroid hormone Substances 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 229960000310 isoleucine Drugs 0.000 description 2
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 2
- 208000032839 leukemia Diseases 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 230000015654 memory Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 229930182817 methionine Natural products 0.000 description 2
- 230000004089 microcirculation Effects 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 235000008935 nutritious Nutrition 0.000 description 2
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 230000005195 poor health Effects 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- ZCCUUQDIBDJBTK-UHFFFAOYSA-N psoralen Chemical compound C1=C2OC(=O)C=CC2=CC2=C1OC=C2 ZCCUUQDIBDJBTK-UHFFFAOYSA-N 0.000 description 2
- 229960002477 riboflavin Drugs 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 210000004706 scrotum Anatomy 0.000 description 2
- 210000003491 skin Anatomy 0.000 description 2
- 208000017520 skin disease Diseases 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 230000002381 testicular Effects 0.000 description 2
- 229960003495 thiamine Drugs 0.000 description 2
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 2
- 229960000716 tonics Drugs 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 235000010374 vitamin B1 Nutrition 0.000 description 2
- 239000011691 vitamin B1 Substances 0.000 description 2
- 235000019166 vitamin D Nutrition 0.000 description 2
- 239000011710 vitamin D Substances 0.000 description 2
- 150000003710 vitamin D derivatives Chemical class 0.000 description 2
- 229940046008 vitamin d Drugs 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- LIEMBEWXEZJEEZ-INEUFUBQSA-N (2r,3r)-4-(6-aminopurin-9-yl)-2,3-dihydroxybutanoic acid Chemical compound NC1=NC=NC2=C1N=CN2C[C@@H](O)[C@@H](O)C(O)=O LIEMBEWXEZJEEZ-INEUFUBQSA-N 0.000 description 1
- DWNBOPVKNPVNQG-LURJTMIESA-N (2s)-4-hydroxy-2-(propylamino)butanoic acid Chemical compound CCCN[C@H](C(O)=O)CCO DWNBOPVKNPVNQG-LURJTMIESA-N 0.000 description 1
- RAFAVNTVTXJMAQ-UHFFFAOYSA-N (3-hydroxyfuran-2-yl)-phenylmethanone Chemical compound OC1=C(OC=C1)C(C1=CC=CC=C1)=O RAFAVNTVTXJMAQ-UHFFFAOYSA-N 0.000 description 1
- GOLORTLGFDVFDW-UHFFFAOYSA-N 3-(1h-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one Chemical compound C1=CC=C2NC(C3=CC4=CC=C(C=C4OC3=O)N(CC)CC)=NC2=C1 GOLORTLGFDVFDW-UHFFFAOYSA-N 0.000 description 1
- VXGRJERITKFWPL-UHFFFAOYSA-N 4',5'-Dihydropsoralen Natural products C1=C2OC(=O)C=CC2=CC2=C1OCC2 VXGRJERITKFWPL-UHFFFAOYSA-N 0.000 description 1
- 208000030507 AIDS Diseases 0.000 description 1
- 206010001580 Albuminuria Diseases 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 201000004813 Bronchopneumonia Diseases 0.000 description 1
- 206010006956 Calcium deficiency Diseases 0.000 description 1
- 206010008570 Chloasma Diseases 0.000 description 1
- 241001478240 Coccus Species 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 201000006306 Cor pulmonale Diseases 0.000 description 1
- KQLDDLUWUFBQHP-UHFFFAOYSA-N Cordycepin Natural products C1=NC=2C(N)=NC=NC=2N1C1OCC(CO)C1O KQLDDLUWUFBQHP-UHFFFAOYSA-N 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- PNNNRSAQSRJVSB-SLPGGIOYSA-N Fucose Natural products C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-SLPGGIOYSA-N 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- 206010064571 Gene mutation Diseases 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 241000590002 Helicobacter pylori Species 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- 208000000913 Kidney Calculi Diseases 0.000 description 1
- SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 229920001491 Lentinan Polymers 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 206010029148 Nephrolithiasis Diseases 0.000 description 1
- 206010029164 Nephrotic syndrome Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 108091005461 Nucleic proteins Proteins 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 240000002948 Ophiopogon intermedius Species 0.000 description 1
- 206010033307 Overweight Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 102000004503 Perforin Human genes 0.000 description 1
- 108010056995 Perforin Proteins 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 208000028872 Progressive muscular dystrophy Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000004186 Pulmonary Heart Disease Diseases 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 206010044302 Tracheitis Diseases 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 210000001766 X chromosome Anatomy 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 206010048259 Zinc deficiency Diseases 0.000 description 1
- AJIJXGJPCVLICH-UHFFFAOYSA-N [Cl].NC(N)=O Chemical compound [Cl].NC(N)=O AJIJXGJPCVLICH-UHFFFAOYSA-N 0.000 description 1
- LPQOADBMXVRBNX-UHFFFAOYSA-N ac1ldcw0 Chemical compound Cl.C1CN(C)CCN1C1=C(F)C=C2C(=O)C(C(O)=O)=CN3CCSC1=C32 LPQOADBMXVRBNX-UHFFFAOYSA-N 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 230000000879 anti-atherosclerotic effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000002460 anti-migrenic effect Effects 0.000 description 1
- 230000002790 anti-mutagenic effect Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 210000003056 antler Anatomy 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 235000021152 breakfast Nutrition 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 230000005907 cancer growth Effects 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 239000000496 cardiotonic agent Substances 0.000 description 1
- 230000009084 cardiovascular function Effects 0.000 description 1
- 230000032677 cell aging Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- OFEZSBMBBKLLBJ-BAJZRUMYSA-N cordycepin Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)C[C@H]1O OFEZSBMBBKLLBJ-BAJZRUMYSA-N 0.000 description 1
- OFEZSBMBBKLLBJ-UHFFFAOYSA-N cordycepine Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(CO)CC1O OFEZSBMBBKLLBJ-UHFFFAOYSA-N 0.000 description 1
- 229940109239 creatinine Drugs 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 201000001981 dermatomyositis Diseases 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 208000030172 endocrine system disease Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 229910052732 germanium Inorganic materials 0.000 description 1
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 229940037467 helicobacter pylori Drugs 0.000 description 1
- 206010019847 hepatosplenomegaly Diseases 0.000 description 1
- 239000010903 husk Substances 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000000509 infertility Diseases 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 231100000535 infertility Toxicity 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 229940115286 lentinan Drugs 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 235000020845 low-calorie diet Nutrition 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 206010025135 lupus erythematosus Diseases 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 206010027175 memory impairment Diseases 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 239000002366 mineral element Substances 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 201000000585 muscular atrophy Diseases 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 208000009928 nephrosis Diseases 0.000 description 1
- 231100001027 nephrosis Toxicity 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 150000002972 pentoses Chemical class 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 201000007094 prostatitis Diseases 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000008327 renal blood flow Effects 0.000 description 1
- 210000003705 ribosome Anatomy 0.000 description 1
- 208000007442 rickets Diseases 0.000 description 1
- 229920002477 rna polymer Polymers 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000035946 sexual desire Effects 0.000 description 1
- 239000002893 slag Substances 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 208000006379 syphilis Diseases 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019160 vitamin B3 Nutrition 0.000 description 1
- 239000011708 vitamin B3 Substances 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 230000002747 voluntary effect Effects 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/066—Clavicipitaceae
- A61K36/068—Cordyceps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/074—Ganoderma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Mycology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
- Cosmetics (AREA)
Abstract
本发明涉及一种具有生发的活性菌丝群组合物,还涉及该活性菌丝群组合物的制备方法。按重量百分比由黑木耳菌丝体25~30%、野灵芝菌丝体20~24%、松茸菌丝体5~7%、毛尖蘑菌丝体5~7%、冬虫夏草菌丝体4~6%、黑牛肝菌丝体4~6%、金针菇菌丝体4~6%、香菇菌丝体4~6%、羊肚菇菌丝体3~5%、榆黄蘑菌丝体3~5%、茶树菇菌丝体3~5%、银耳菌丝体3~5组成。本发明产品具有生发的作用,可用于秃顶、毛发稀少的人群使用。
Description
技术领域
本发明涉及一种具有生发的活性菌丝群组合物,还涉及该活性菌丝群组合物的制备方法。
背景技术
目前秃顶已经迫不及待的像年轻人的大军靠拢,自然导致一部分兴致勃发的阳光男孩俨然一副大叔的模样。秃顶与人体中的X染色体有关,所以秃顶是由遗传因素决定的,但是与此同时,我们还发现:秃顶和雄性激素的分泌量有直接的关系。再加上环境的影响、不良的生活习惯或者是精神压力,都可能导致秃顶加剧。如果是在秃顶的前期,我们可以进行药物治疗,因为这个时候的毛囊可能只是萎缩,只要及时治疗,萎缩的毛囊就有恢复的可能。但是如果脱发时间超过一年以上,毛囊完全坏死,就没有办法长出新的毛发了,而且药物对于坏死的毛囊也是无济于事,所以对于永久性秃顶,就只能进行植发手术进行解决。植发打破了传统药物的治疗方式,利用毛囊分散提取的方式,将后枕部健康的毛囊提取出来,然后艺术种植到秃顶部位,从而使的缺发部位重新拥有新的毛囊,长出新的毛发。但是并不是所有的秃顶都可以进行手术。如果秃顶面积过大、后枕部的毛囊供体不足,很有可能导致术后效果不理想。目前正缺乏一种既能生发,又能保健,而且没有任何激素类添加剂,纯绿色天然的生物活性菌丝保健品。
发明内容
本发明的目的是克服现有技术的不足,提供一种无毒副作用,具有生发的活性菌丝群组合物。本发明的另一目的是提供一种该组合物的制备方法。
本发明一种具有生发的活性菌丝群组合物,按重量百分比由黑木耳菌丝体25~30%、野灵芝菌丝体20~24%、松茸菌丝体5~7%、毛尖蘑菌丝体5~7%、冬虫夏草菌丝体4~6%、黑牛肝菌丝体4~6%、金针菇菌丝体4~6%、香菇菌丝体4~6%、羊肚菇菌丝体3~5%、榆黄蘑菌丝体3~5%、茶树菇菌丝体3~5%、银耳菌丝体3~5组成。
按重量百分比,本发明的优选方案,由黑木耳菌丝体26~31%、野灵芝菌丝体20~24%、松茸菌丝体6~8%、毛尖蘑菌丝体6~8%、冬虫夏草菌丝体4~6%、黑牛肝菌丝体4~6%、金针菇菌丝体4~6%、香菇菌丝体4~6%、羊肚菇菌丝体3~5%、榆黄蘑菌丝体3~5%、茶树菇菌丝体3~5%、银耳菌丝体3~5%组成。
按重量百分比,本发明的最优选方案,由黑木耳菌丝体30%、野灵芝菌丝体20%、松茸菌丝体7%、毛尖蘑菌丝体7%、冬虫夏草菌丝体5%、黑牛肝菌丝体5%、金针菇菌丝体5%、香菇菌丝体5%、羊肚菇菌丝体4%、榆黄蘑菌丝体4%、茶树菇菌丝体4%、银耳菌丝体4%组成。
以上所述的一种具有生发的活性菌丝群组合物,可制成任何一种药剂学上所述的剂型。
以上所述的一种具有生发的活性菌丝群组合物,优选的剂型是酒剂、胶囊或片剂。
一种具有生发的活性菌丝群组合物的制备方法如下:
1、黑木耳菌丝体的制备方法:野生黑木耳经过组织分离、培养、提取、浓缩、冻干、真空干燥,得到黑木耳菌丝体;
2、野灵芝菌丝体的制备方法:野灵芝经过组织分离、培养、提取、浓缩、冻干、真空干燥,得到野灵芝菌丝体;
3、松茸菌丝体的制备方法:松茸经过组织分离、培养、提取、浓缩、冻干、真空干燥,得到松茸菌丝体;
4、毛尖蘑菌丝体的制备方法:野生毛尖蘑经过组织分离、培养、提取、浓缩、冻干、真空干燥,得到毛尖蘑菌丝体;
5、冬虫夏草菌丝体的制备方法:野生冬虫夏草经过组织分离、培养、提取、浓缩、冻干、真空干燥,得到冬虫夏草菌丝体;
6、黑牛肝菌丝体的制备方法:野生黑牛肝经过组织分离、培养、提取、浓缩、冻干、真空干燥,得到黑牛肝菌丝体;
7、金针菇菌丝体的制备方法:金针菇经过组织分离、培养、提取、浓缩、冻干、真空干燥,得到金针菇菌丝体;
8、香菇菌丝体的制备方法:野生香菇经过组织分离、培养、提取、浓缩、冻干、真空干燥,得到香菇菌丝体;
9、羊肚菇菌丝体的制备方法:野生羊肚菇经过组织分离、培养、提取、浓缩、冻干、真空干燥,得到羊肚菇菌丝体;
10、榆黄蘑菌丝体的制备方法:野生榆黄蘑经过组织分离、培养、提取、浓缩、冻干、真空干燥,得到榆黄蘑菌丝体;
11、茶树菇菌丝体的制备方法:野生茶树菇经过组织分离、培养、提取、浓缩、冻干、真空干燥,得到茶树菇菌丝体;
12、银耳菌丝体的制备方法:野生银耳经过组织分离、培养、提取、浓缩、冻干、真空干燥,得到银耳菌丝体;
13、将上述制得的黑木耳菌丝体、野灵芝菌丝体、松茸菌丝体、毛尖蘑菌丝体、冬虫夏草菌丝体、黑牛肝菌丝体、金针菇菌丝体、香菇菌丝体、羊肚菇菌丝体、榆黄蘑菌丝体、茶树菇菌丝体、银耳菌丝体分别进行粉碎、磨粉,按比例混合均匀,过300目的筛子,制成300目的细粉,把经灭菌处理好的细粉装入胶囊,就制得一种具有生发的活性菌丝群组合物的胶囊;
把经灭菌处理好的散剂进行压片处理,就制得一种具有生发的活性菌丝群组合物的片剂。
把经灭菌处理好的粉剂装入300目的过滤网,再浸入60度的纯粮食大曲发酵酒中进行6至12个月的二次发酵,经过调配、过滤,就制得一种具有生发的活性菌丝群组合物的酒剂。
本发明一种具有生发的活性菌丝群组合物选择黑木耳菌丝体、野灵芝菌丝体、松茸菌丝体、毛尖蘑菌丝体、冬虫夏草菌丝体、黑牛肝菌丝体、金针菇菌丝体、香菇菌丝体、羊肚菇菌丝体、榆黄蘑菌丝体、茶树菇菌丝体、银耳菌丝体进行组合,使得各种菌丝体功效产生协同作用,从而达到生发的目的。各种菌丝体主要成分及功效:
黑木耳菌丝体含有多糖、麦角淄醇、维生素B2、黑刺菌素、氨基酸、蛋白质、脂质、胡萝卜素、钾、钠、钙、镁、铜、锌、锰、磷等其他微量元素。其主要功效:
(1)养血驻颜,令人肌肤红润、容光焕发、瘦身美容。
(2)防止缺铁性贫血、降低血管内凝血、防止动脉硬化和冠心病、脑血栓。
(3)清除血管及胃肠垃圾、活血补血、健脾胃、助排泄、减轻胃肠负担,加速胃肠内毒素和废弃物的排泄。
(4)对胆、肾结石等内源性异物有明显化解功能。
(5)降胆固醇、血脂、防止动脉硬化。
(6)对无意中吃下的头发、谷物、谷壳、木渣、沙子、金属屑等异物有溶解与氧化作用。
(7)抗辐射及抗炎、抗溃疡、抗基因突变。
(8)强心、清肺润肺、调节内分泌、失调等功能。
野灵芝菌丝体含有多糖、蛋白质、多种氨基酸、多肽类、麦角淄醇、甘露醇、生物碱、香豆精、淄体皂苷、腺嘌呤、多种酶、多种微量元素、维生素B2、维生素C等。主要功效:
(1)增强免疫功能、扶正固本、抗各种过敏体质、红斑狼疮、皮肤病、补内脏元气。
(2)白细胞减少症、白血病、长期感冒、咳喘、肺结核、淋巴结核。
(3)冠心病、心绞痛、心悸气短、心律失常、失眠多梦、降胆固醇、甘油三脂、预防动脉粥样硬化斑块的形成,改善微循环。
(4)对脾胃功能减弱、胃癌、肝癌、肿瘤都起到很好的作用。
(5)安神、镇静、抗惊厥、增智慧,对神经衰弱、头痛、头晕效果显著,对气血两虚、月经不调、痛经、闭经、更年期综合症提前更为适宜。
(6)糖尿病、进行性肌营养不良、萎缩性肌强直高源反应。抗衰老、排毒养颜。
(7)对癌症、肿瘤病人有辅助治疗,长期服用可养发护发。
松茸菌丝体含有蛋白质、脂肪和多种氨基酸、维生素B1、B2、C和PP纤维素,不饱和脂肪酸;葡萄糖酸,核酸衍生物,肽类物质,有机锗Gel24-239PM,多糖LPB等稀有营养元素,具有提高SOD活性。主要功效:
(1)提高免疫力,增加抗病毒能力。气管炎,支气管肺炎,理气化痰,止咳平喘,肺炎双球菌,链球菌,对流感病毒有抑制作用。
(2)加速自由基的清除,延缓组织器官衰退,改善心血管功能,促进新陈代谢,提高人体免疫力,抗病毒,抗细胞突变的能力。
(3)对心脑供血不足,失眠,健忘,偏头痛,心烦,贫血,高血压,高血脂,糖尿病,动脉硬化有很好的疗效。
(4)疲乏无力,肢体困倦,胸膈满闷,恶心呕吐,脾胃功能失调,食欲不振,益胃补气,健脑益智。
(5)抗癌,抑制肿瘤,抑制癌细胞生长和扩散。
(6)补骨生髓,对骨关节疼痛有很好的疗效。
(7)对肾功能低下引起的腰酸腿软,阴囊潮湿,睾丸衰老,前列腺炎,尿频,尿痛,尿路感染,遗尿,增加肾血流量,强精补肾,恢复精力,增加雄性激素,解决性功能障碍。
毛尖蘑菌丝体含有人体所需的18种氨基酸,特别是含有人体所不能合成的8种氨基酸、葡聚糖、菌蛋白、碳水化合物等营养成分;还有丰富的B族维生素和铁、钾、锌、硒等矿物质元素;其有效成分是其它菇类的好几倍乃至十几倍。其主要功效为:
(1)抗溃疡和抗炎作用。
(2)抗肿瘤作用。
(3)保肝护肝作用。
(4)降血脂及抗动脉粥样硬化的作用。
(5)增加免疫力,抗衰老作用。
(6)对核酸和蛋白生物合成的影响。
(7)提高机体耐缺氧能力,增加心脏血液输出量,加速机体血液循环。
(8)降低血糖的作用。
(9)抗辐射及抗炎作用。
(10)抗癌、抗突变作用。
冬虫夏草菌丝体具有阴阳双补,起萎固精,益阴补肺之功效。虫草主要成份:虫草酸、虫草素、氨基酸、甾醇、甘露醇、生物碱、维生素 B1 、 B2 、多糖及矿物质等。主要功效:
(1)提高肾功能,对肾病可以迅速清除蛋白尿,水肿,血尿、尿素氯,血肌肝,升高血清蛋白,改善贫血,排肾毒,延缓肾功能衰竭的发生,补肾,壮阳,对男女性欲功能减退,阳萎,早泄,阴囊潮湿,腰酸腿软,头昏,耳鸣,肌肉萎缩,皮肌炎有奇特功效。
(2)对慢性气管炎有,肺源性心脏病,反复感冒,咳嗽,气喘,身体虚弱,全身瘙痒,恶心呕吐,失眠健忘,盗汗,结核杆菌,肺炎链球菌有很好的疗效。
(3)延缓细胞衰老,美容,瘦身,丰胸,预防睾丸衰老,阴阳双补。
(4)软化血管,降血脂,降血糖,改善心肌缺血,搞心律失常,镇静,抗惊厥,防止动脉硬化。
(5)对各种癌症及各种恶性肿瘤能得到改善和抑制,提高记忆力,调节内分泌系统和神经系统。
黑牛肝菌丝体含有人体必需的8种氨基酸,含有腺膘呤、胆碱和多糖。组成牛肝菌多糖的单糖,有葡萄糖、半乳糖、甘露糖、木糖和岩藻糖等。主要功效:
(1)治疗腰腿疼痛、手足麻木、四肢抽搐,还可用以治妇女白带异常和不孕症。
(2)它具有清热解烦、养血和中、追风散寒、舒筋活血、补虚提神等功效。
(3)另外,还有较强的抗癌活性、抗流感病毒、防治感冒的作用。经常服用黑牛肝菌菌丝体可明显增强机体免疫力、改善机体微循环。
金针菇菌丝体含维生素B、维生素C、蛋白质、碳水化合物、矿物质、粗纤维、胡罗卜素、多种维生素、氨基酸、多糖、牛磺酸、香菇嘌呤、麦冬淄醇、细胞溶解素、冬菇细胞素等有益成分。主要功效:
(1)增加智慧、提高记忆力、抗衰老,预防中老年痴呆。
(2)调节肠胃功能、防止便秘、消化道溃疡、胃肠炎、抗疲劳。
(3)清除重金属、盐类对身体的伤害,有效地增加机体的生物活性,促进体内新陈代谢,有利于食物中各种营养的吸收和利用。
(4)增强机体对癌细胞的抗御能力,降血压、降血糖、降血脂、降胆固醇,对肥胖者更为适宜。
(5)调节人体酸碱度,对早期癌症有很好的抑制作用,抗癌、防癌。
(6)抗各种细菌、病菌,对分支孢菌、枯草杆菌有抑制作用。
(7)促进儿童智力发育和健脑,对儿童、青少年生长发育缓慢、发育不良、多动症、痴呆、缺钙、缺锌现象,能增强骨骼,对钙和锌有很好的吸收。
香菇菌丝体含有一种分子量为100万的抗肿瘤成分——香菇多糖,含有降低血脂的成分——香菇太生,香菇腺嘌呤的衍生物,还含有抗病毒成分——干扰素的诱发剂:双链糖核酸,蛋白质18.64%、脂肪4.8%、碳水化合物71%、异亮氨酸、笨丙氨酸、蛋氨酸、苏氨酸、缬氨酸等7种人体必须的氨基酸,还含有大量的可转变维生素D的麦角淄醇和菌淄醇,B1、B2、PP及矿物盐和粗纤维,钙、磷、铁、尼克酸、可溶性无氨物质等。主要功效:
(1)降血脂、降血压、抗血栓、降血糖、安心安神、心悸、失眠、养精神、安魂魄、小儿惊厥、心腹胀满、补脑养骨髓。
(2)水湿停滞、小便不利、水肿、健脾补中益气不饥。对性病、梅毒、艾滋病、疱疹病毒、幽门螺旋杆菌、治风破血、膀胱湿热、大肠杆菌。
(3)抗病毒、防感冒、止咳、化痰、平喘、肺炎链球菌、孢子球菌有抑制作用,控制结核病的发生。
(4)健脾助消化:食欲不振、身体虚弱、大便不正常、便秘。开胃止呕、口苦舌干;逐水暖脾、生律益气、平火止泻,对肝脾肿大也有一定的好处。
(5)对婴幼儿因缺乏维生素D引起的血磷、血钙代谢障碍导致的佝偻病有很好的调节作用。
(6)对皮肤病、白血病、内分泌失调、快速增加免疫功能,使钙得到很好作用。
(7)有补肝肾、健脾胃、益气血、益智安神、养容颜之功效。
(8)对癌细胞有强烈的抑制作用:结肠癌、肺癌、乳腺癌。晚期癌症长期服用本品在化疗时间改善病人免疫功能,提高疗效、延长生存期。
羊肚菇菌丝体可药用,益肠胃,化痰理气。含有异亮氨酸、亮氨酸、赖氨酸、蛋氨酸、苯丙氨酸、苏氨酸和缬氨酸等7种人体必需氨基酸。含有丰富的蛋白质、脂肪、碳水化合物,还含有多种维生素和矿物质。主要功效:具有补肾、壮阳、补脑、提神的功能。对头晕、失眠、肠胃炎症、脾胃虚弱、消化不良等有治疗作用,还可防癌、抗癌、预防感冒。
榆黄蘑菌丝体营养丰富,含蛋白质、维生素和矿物质等多种营养成分,其中氨基酸含量尤为丰富,且必需氨基酸含量高,属高营养、低热量食品,长期食用,有降低血压、降低胆固醇含量的功能,是老年人心血管疾病患者和肥胖症患者的理想保健食品。可入药,治虚弱萎症(肌萎)和痢疾等症。具有滋补强壮功效。
银耳菌丝体含有17种氨基酸、多种矿物质,其中钙、铁的含量很高以及海藻糖、多缩戊糖、甘露糖醇等肝糖。
茶树菇菌丝体营养丰富,蛋白质含量高达19.55%。所含蛋白质中有18种氨基酸,其中,人体不能自身合成的8种氨基酸含量特别高,并且有丰富的B族维生素和钾、钠、钙、镁、铁、锌等矿质元素。其主要功能为: 1.利尿、渗湿,2.美容、降血压,3.增强免疫力,抗癌、抗衰老。
银耳能提高肝脏解毒能力,保护肝脏功能,它不但能增强机体抗肿瘤的免疫能力,还能增强肿瘤患者对放疗、化疗的耐受力。它也是一味滋补良药,特点是滋润而不腻滞,具有补脾开胃、益气清肠、安眠健胃、补脑、养阴清热、润燥之功,对阴虚火旺不受参茸等温热滋补的病人是一种良好的补品。银耳富有天然特性胶质,加上它的滋阴作用,长期服用可以润肤,并有祛除脸部黄褐斑、雀斑的功效。银耳是和种含膳食纤维的减肥食品,它的膳食纤维可助胃肠蠕动,减少脂肪吸收。
纵观该生发的活性菌丝群组合物,是一个多种菌丝体组合在一起的,以黑木耳菌丝体、野灵芝丝体为主,其他菌丝体为辅,组成的复方,由于组方严谨、相得益彰、功效显著。
具体实施方式
下面结合具体实施例对本发明进一步进行描述:
实施例1:
本发明一种具有生发的活性菌丝群组合物,按重量百分比由黑木耳菌丝体30%、野灵芝菌丝体20%、松茸菌丝体7%、毛尖蘑菌丝体7%、冬虫夏草菌丝体5%、黑牛肝菌丝体5%、金针菇菌丝体5%、香菇菌丝体5%、羊肚菇菌丝体4%、榆黄蘑菌丝体4%、茶树菇菌丝体4%、银耳菌丝体4%组成。
实施例2:
本发明的一种具有生发的活性菌丝群组合物,按重量百分比由黑木耳菌丝体26%、野灵芝菌丝体24%、松茸菌丝体7%、毛尖蘑菌丝体7%、冬虫夏草菌丝体6%、黑牛肝菌丝体6%、金针菇菌丝体4%、香菇菌丝体4%、羊肚菇菌丝体5%、榆黄蘑菌丝体5%、茶树菇菌丝体3%、银耳菌丝体3%组成。
实施例3:
本发明的一种具有生发的活性菌丝群组合物,按重量百分比由黑木耳菌丝体25%、野灵芝菌丝体20%、松茸菌丝体6%、毛尖蘑菌丝体6%、冬虫夏草菌丝体7%、黑牛肝菌丝体7%、金针菇菌丝体7%、香菇菌丝体7%、羊肚菇菌丝体5%、榆黄蘑菌丝体5%、茶树菇菌丝体3%、银耳菌丝体2%组成。
实施例4:
本发明的一种具有生发的活性菌丝群组合物,按重量百分比由黑木耳菌丝体24%、野灵芝菌丝体22%、松茸菌丝体7%、毛尖蘑菌丝体6%、冬虫夏草菌丝体6%、黑牛肝菌丝体6%、金针菇菌丝体6%、香菇菌丝体6%、羊肚菇菌丝体4%、榆黄蘑菌丝体4%、茶树菇菌丝体5%、银耳菌丝体4%组成。
实施例5:
一种具有生发的活性菌丝群组合物的制备方法如下:
1、黑木耳菌丝体的制备方法:野生黑木耳经过组织分离、培养、提取、浓缩、冻干、真空干燥,得到黑木耳菌丝体;
2、野灵芝菌丝体的制备方法:野灵芝经过组织分离、培养、提取、浓缩、冻干、真空干燥,得到野灵芝菌丝体;
3、松茸菌丝体的制备方法:野松茸经过组织分离、培养、提取、浓缩、冻干、真空干燥,得到松茸菌丝体;
4、毛尖蘑菌丝体的制备方法:野生毛尖蘑经过组织分离、培养、提取、浓缩、冻干、真空干燥,得到毛尖蘑菌丝体;
5、冬虫夏草菌丝体的制备方法:野生冬虫夏草经过组织分离、培养、提取、浓缩、冻干、真空干燥,得到冬虫夏草菌丝体;
6、黑牛肝菌丝体的制备方法:野生黑牛肝经过组织分离、培养、提取、浓缩、冻干、真空干燥,得到黑牛肝菌丝体;
7、金针菇菌丝体的制备方法:金针菇经过组织分离、培养、提取、浓缩、冻干、真空干燥,得到金针菇菌丝体;
8、香菇菌丝体的制备方法:野生香菇经过组织分离、培养、提取、浓缩、冻干、真空干燥,得到香菇菌丝体;
9、羊肚菇菌丝体的制备方法:野生羊肚菇经过组织分离、培养、提取、浓缩、冻干、真空干燥,得到羊肚菇菌丝体;
10、榆黄蘑菌丝体的制备方法:野生榆黄蘑经过组织分离、培养、提取、浓缩、冻干、真空干燥,得到榆黄蘑菌丝体;
11、茶树菇菌丝体的制备方法:野生茶树菇经过组织分离、培养、提取、浓缩、冻干、真空干燥,得到茶树菇菌丝体;
12、银耳菌丝体的制备方法:野生银耳经过组织分离、培养、提取、浓缩、冻干、真空干燥,得到银耳菌丝体;
13、将上述制得的黑木耳菌丝体、野灵芝菌丝体、松茸菌丝体、毛尖蘑菌丝体、冬虫夏草菌丝体、黑牛肝菌丝体、金针菇菌丝体、香菇菌丝体、羊肚菇菌丝体、榆黄蘑菌丝体、茶树菇菌丝体、银耳菌丝体分别进行粉碎、磨粉,按比例混合均匀,过300目的筛子,制成300目的细粉,把经灭菌处理好的细粉装入胶囊,就制得一种具有生发的活性菌丝群组合物的胶囊;
把经灭菌处理好的散剂进行压片处理,就制得一种具有生发的活性菌丝群组合物的片剂。
把经灭菌处理好的粉剂装入300目的过滤网,再浸入60度的纯粮食大曲发酵酒中进行6至12个月的二次发酵,经过调配、过滤,就制得一种具有生发的活性菌丝群组合物的酒剂。
本发明一种具有生发的活性菌丝群组合物治疗效果:
在患者同意的情况下,使用该具有生发的活性菌丝群组合物,对20例秃顶患者进行了治疗。在病人自愿的前提下,服用本发明具有生发的活性菌丝群组合物,每日二次, 早饭前、晚上睡觉前服用,温水送服,连服15天,为1疗程,连续服用6个疗程。
治疗效果:其中19例患者新生发的效果很明显,而且睡眠得到改善, 1例患者效果不明显。
Claims (6)
1.一种具有生发的活性菌丝群组合物,其特征在于:黑木耳菌丝体26~31%、野灵芝菌丝体20~24%、松茸菌丝体6~8%、毛尖蘑菌丝体6~8%、冬虫夏草菌丝体4~6%、黑牛肝菌丝体4~6%、金针菇菌丝体4~6%、香菇菌丝体4~6%、羊肚菇菌丝体3~5%、榆黄蘑菌丝体3~5%、茶树菇菌丝体3~5%、银耳菌丝体3~5%组成。
2.根据权利要求1所述的一种具有生发的活性菌丝群组合物,其特征在于:按重量百分比由黑木耳菌丝体26~31%、野灵芝菌丝体20~24%、松茸菌丝体6~8%、毛尖蘑菌丝体6~8%、冬虫夏草菌丝体4~6%、黑牛肝菌丝体4~6%、金针菇菌丝体4~6%、香菇菌丝体4~6%、羊肚菇菌丝体3~5%、榆黄蘑菌丝体3~5%、茶树菇菌丝体3~5%、银耳菌丝体3~5%组成。
3.根据权利要求2所述的一种具有生发的活性菌丝群组合物,其特征在于:按重量百分比由黑木耳菌丝体26~31%、野灵芝菌丝体20~24%、松茸菌丝体6~8%、毛尖蘑菌丝体6~8%、冬虫夏草菌丝体4~6%、黑牛肝菌丝体4~6%、金针菇菌丝体4~6%、香菇菌丝体4~6%、羊肚菇菌丝体3~5%、榆黄蘑菌丝体3~5%、茶树菇菌丝体3~5%、银耳菌丝体3~5%组成。
4.根据权利要求1~3任一所述的一种具有生发的活性菌丝群组合物,其特征在于:所述的剂型是任何一种药剂学上所述的剂型。
5.根据权利要求4所述的一种具有生发的活性菌丝群组合物,其特征在于:所述的剂型是片剂、胶囊或酒剂。
6.根据权利要求1~5任一所述的一种具有生发的活性菌丝群组合物的制备方法,其特征在于,包含以下步骤:
1)、黑木耳菌丝体的制备方法:野生黑木耳经过组织分离、培养、提取、浓缩、冻干、真空干燥,得到黑木耳菌丝体;
2)、野灵芝菌丝体的制备方法:野灵芝经过组织分离、培养、提取、浓缩、冻干、真空干燥,得到野灵芝菌丝体;
3)、松茸菌丝体的制备方法:野松茸经过组织分离、培养、提取、浓缩、冻干、真空干燥,得到松茸菌丝体;
4)、毛尖蘑菌丝体的制备方法:野生毛尖蘑经过组织分离、培养、提取、浓缩、冻干、真空干燥,得到毛尖蘑菌丝体;
5)、冬虫夏草菌丝体的制备方法:野生冬虫夏草经过组织分离、培养、提取、浓缩、冻干、真空干燥,得到冬虫夏草菌丝体;
6)、黑牛肝菌丝体的制备方法:野生黑牛肝经过组织分离、培养、提取、浓缩、冻干、真空干燥,得到黑牛肝菌丝体;
7)、金针菇菌丝体的制备方法:金针菇经过组织分离、培养、提取、浓缩、冻干、真空干燥,得到金针菇菌丝体;
8)、香菇菌丝体的制备方法:野生香菇经过组织分离、培养、提取、浓缩、冻干、真空干燥,得到香菇菌丝体;
9)、羊肚菇菌丝体的制备方法:野生羊肚菇经过组织分离、培养、提取、浓缩、冻干、真空干燥,得到羊肚菇菌丝体;
10)、榆黄蘑菌丝体的制备方法:野生榆黄蘑经过组织分离、培养、提取、浓缩、冻干、真空干燥,得到榆黄蘑菌丝体;
11)、茶树菇菌丝体的制备方法:野生茶树菇经过组织分离、培养、提取、浓缩、冻干、真空干燥,得到茶树菇菌丝体;
12)、银耳菌丝体的制备方法:野生银耳经过组织分离、培养、提取、浓缩、冻干、真空干燥,得到银耳菌丝体;
13)、将上述制得的冬虫夏草菌丝体、松茸菌丝体、野灵芝菌丝体、毛尖蘑菌丝体、黑木耳菌丝体、黑牛肝菌丝体、金针菇菌丝体、香菇菌丝体、羊肚菇菌丝体、榆黄蘑菌丝体、茶树菇菌丝体、银耳菌丝体分别进行粉碎、磨粉,按比例混合均匀,过300目的筛子,制成300目的细粉,把经灭菌处理好的细粉装入胶囊,就制得一种具有生发的活性菌丝群组合物的胶囊;或者把经灭菌处理好的散剂进行压片处理,就制得一种具有生发的组合物的片剂;又或者把经灭菌处理好的粉剂装入300目的过滤网,再浸入60度的纯粮食大曲发酵酒中进行6至12个月的二次发酵,经过调配、过滤,就制得一种具有生发的活性菌丝群组合物的酒剂。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610127597.5A CN107156801A (zh) | 2016-03-08 | 2016-03-08 | 一种具有生发的活性菌丝群组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610127597.5A CN107156801A (zh) | 2016-03-08 | 2016-03-08 | 一种具有生发的活性菌丝群组合物及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107156801A true CN107156801A (zh) | 2017-09-15 |
Family
ID=59849266
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610127597.5A Pending CN107156801A (zh) | 2016-03-08 | 2016-03-08 | 一种具有生发的活性菌丝群组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107156801A (zh) |
Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1303632A (zh) * | 2000-05-12 | 2001-07-18 | 钱师良 | 紫芝保健饮料 |
KR20100118225A (ko) * | 2009-04-28 | 2010-11-05 | 한불화장품주식회사 | 버들송이 추출물을 함유하는 피부 외용제 조성물 |
CN102424625A (zh) * | 2011-08-30 | 2012-04-25 | 大连百祥聚生物科技有限公司 | 一种食药用菌乌发剂、其制备方法及用途 |
CN103564491A (zh) * | 2013-10-18 | 2014-02-12 | 伊春林业科学院 | 蓝莓香菇复合抗氧化胶囊 |
CN104106799A (zh) * | 2014-08-13 | 2014-10-22 | 及长城 | 一种具有清除体内毒素作用的组合物及其制备方法 |
CN104126785A (zh) * | 2014-08-03 | 2014-11-05 | 及长城 | 一种具有降糖作用的组合物及其制备方法 |
CN104147383A (zh) * | 2014-07-26 | 2014-11-19 | 及长城 | 一种抗肿瘤的组合物及其制备方法 |
CN104223081A (zh) * | 2014-09-28 | 2014-12-24 | 青岛金佳慧食品有限公司 | 一种缓解头发脱落的食品 |
CN104286828A (zh) * | 2014-09-24 | 2015-01-21 | 杜超峰 | 一种松茸维生素组合物及松茸醇、松茸多糖的制备方法 |
CN104905339A (zh) * | 2015-06-05 | 2015-09-16 | 李德富 | 菌菇汤及其熬制方法 |
CN105288226A (zh) * | 2014-07-15 | 2016-02-03 | 及长城 | 一种补肾壮阳的组合物及其制备方法 |
-
2016
- 2016-03-08 CN CN201610127597.5A patent/CN107156801A/zh active Pending
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1303632A (zh) * | 2000-05-12 | 2001-07-18 | 钱师良 | 紫芝保健饮料 |
KR20100118225A (ko) * | 2009-04-28 | 2010-11-05 | 한불화장품주식회사 | 버들송이 추출물을 함유하는 피부 외용제 조성물 |
CN102424625A (zh) * | 2011-08-30 | 2012-04-25 | 大连百祥聚生物科技有限公司 | 一种食药用菌乌发剂、其制备方法及用途 |
CN103564491A (zh) * | 2013-10-18 | 2014-02-12 | 伊春林业科学院 | 蓝莓香菇复合抗氧化胶囊 |
CN105288226A (zh) * | 2014-07-15 | 2016-02-03 | 及长城 | 一种补肾壮阳的组合物及其制备方法 |
CN104147383A (zh) * | 2014-07-26 | 2014-11-19 | 及长城 | 一种抗肿瘤的组合物及其制备方法 |
CN104126785A (zh) * | 2014-08-03 | 2014-11-05 | 及长城 | 一种具有降糖作用的组合物及其制备方法 |
CN104106799A (zh) * | 2014-08-13 | 2014-10-22 | 及长城 | 一种具有清除体内毒素作用的组合物及其制备方法 |
CN104286828A (zh) * | 2014-09-24 | 2015-01-21 | 杜超峰 | 一种松茸维生素组合物及松茸醇、松茸多糖的制备方法 |
CN104223081A (zh) * | 2014-09-28 | 2014-12-24 | 青岛金佳慧食品有限公司 | 一种缓解头发脱落的食品 |
CN104905339A (zh) * | 2015-06-05 | 2015-09-16 | 李德富 | 菌菇汤及其熬制方法 |
Non-Patent Citations (1)
Title |
---|
矫浩然: "《一用就灵:经络通养生全书》", 31 August 2013, 天津:天津科学技术出版社 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103039671B (zh) | 虫草速溶茶 | |
CN104147132A (zh) | 能够降低血糖调节胰岛素分泌的软胶囊及制作方法 | |
CN106473107A (zh) | 一种即食型复合食用菌粉营养素及其制备方法 | |
CN104126785A (zh) | 一种具有降糖作用的组合物及其制备方法 | |
CN104147383A (zh) | 一种抗肿瘤的组合物及其制备方法 | |
CN102144748A (zh) | 具有排毒护肝养颜功能的五色面制食品 | |
CN102697035A (zh) | 虫草褔寿丹 | |
CN102488278A (zh) | 一种具有双功能保健作用的复合真菌营养液 | |
CN102526698A (zh) | 虫草多肽氨基酸营养液 | |
CN103877122A (zh) | 中药阿胶原料的生产方法及其产品 | |
CN105918387A (zh) | 一种适用中老年保健食品及制备方法 | |
CN104479964A (zh) | 一种黄秋葵、菌、藻保健酒及其制备方法 | |
CN101884783A (zh) | 一种含有麦麸多肽的抗疲劳中药及其制备方法 | |
CN103271356B (zh) | 一种增强免疫力、缓解体力疲劳组合物及其制备方法 | |
CN105288226A (zh) | 一种补肾壮阳的组合物及其制备方法 | |
CN108782679A (zh) | 一种减肥干预代餐饼干及其制备方法 | |
CN1203168C (zh) | 一种制备食疗保健醋的方法及用该方法生产的食疗保健醋 | |
CN104106799B (zh) | 一种具有清除体内毒素作用的组合物及其制备方法 | |
CN104906140A (zh) | 一种阿胶及其制备方法与相关设备 | |
CN109527577A (zh) | 一种具有解酒护肝功能的组合物 | |
CN107997125A (zh) | 食用菌菌丝体和\或食用菌菌丝体粉制作工艺及其产品 | |
CN103933146A (zh) | 一种可调节人体免疫力的花粉制品 | |
CN106912921A (zh) | 一种糖尿病全营养配方食品 | |
CN105361149A (zh) | 一种青稞虫草糁子营养粉及其制备方法 | |
CN105941768A (zh) | 一种含有灵芝菌丝的金花茶 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20170915 |
|
WD01 | Invention patent application deemed withdrawn after publication |